Back

Cardiac Sarcoidosis treated with non-steroidal immunosuppressive therapy

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmogenic cardiomyopathy and cardiac sarcoidosis Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Kenichiro Suwa

Hamamatsu University School of Medicine, Hamamatsu (Japan)

6 More presentations in this session

Presentation thumbnail
Correlation between epsilon wave and late potentials in arrythmogenic right ventricular cardiomyopathy. Do late potentials define the epsilon wave?
Doctor U. Skrzypczynska-Banasik (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Influence of left ventricular ejection fraction, type of mutation and sex on malignant ventricular arrhythmias in dsp and flnc mutations
Doctor A. Perez Ferrandiz (Sant Joan d'Alacant, ES)
Abstract Slides Video
Presentation thumbnail
Arrhythmic risk stratification in patients with left ventricular ring-like scar
Doctor V. Parisi (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of family screening in Dilated and Arrhythmogenic Cardiomyopathies
Miss E. Del Mestre (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Arrhythmogenic cardiomyopathy phenotype associated with the pathogenic founder variant c.1211dup in PKP2
Mr T. Bos (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmogenic cardiomyopathy and cardiac sarcoidosis

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and 67gallium scintigraphy in cardiac sarcoidosis.
thumbnail
Congress Presentation
Effects of immunosuppressive therapy on the clinical outcomes in patients with cardiac sarcoidosis
thumbnail
Congress Presentation
Long-term efficacy of tailored prolonged immunosuppressive therapy in biopsy-proven virus- negative myocarditis: a single center propensity weighted study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources